What is Aspire Biopharma Holdings, Inc. Common Stock's Market Cap?

Aspire Biopharma Holdings, Inc. Common Stock's Market Cap is $12.4M, based on as-reported figures from SEC (XBRL) filings.

What is Aspire Biopharma Holdings, Inc. Common Stock's Enterprise Value?

Aspire Biopharma Holdings, Inc. Common Stock's Enterprise Value is $245.5K, based on as-reported figures from SEC (XBRL) filings.

What is Aspire Biopharma Holdings, Inc. Common Stock's Price / Sales?

Aspire Biopharma Holdings, Inc. Common Stock's Price / Sales is 127.1×, based on as-reported figures from SEC (XBRL) filings.

What is Aspire Biopharma Holdings, Inc. Common Stock's EV / Revenue?

Aspire Biopharma Holdings, Inc. Common Stock's EV / Revenue is 2.5×, based on as-reported figures from SEC (XBRL) filings.

What is Aspire Biopharma Holdings, Inc. Common Stock's Revenue (TTM)?

Aspire Biopharma Holdings, Inc. Common Stock's Revenue (TTM) is $97.7K, based on as-reported figures from SEC (XBRL) filings.

What is Aspire Biopharma Holdings, Inc. Common Stock's Net Income (TTM)?

Aspire Biopharma Holdings, Inc. Common Stock's Net Income (TTM) is -$11.0M, based on as-reported figures from SEC (XBRL) filings.

What is Aspire Biopharma Holdings, Inc. Common Stock's Diluted EPS (TTM)?

Aspire Biopharma Holdings, Inc. Common Stock's Diluted EPS (TTM) is -7.88, based on as-reported figures from SEC (XBRL) filings.

What is Aspire Biopharma Holdings, Inc. Common Stock's Net Debt?

Aspire Biopharma Holdings, Inc. Common Stock's Net Debt is -$12.2M, based on as-reported figures from SEC (XBRL) filings.

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) Financial Statements

Aspire Biopharma Holdings, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG015STV142

XNAS · usd

8.85▼ 0.02 (-0.23%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close8.87

Day's Range8.82 – 9.04

52-Week Range0.05 – 9.50

Volume8,660

Avg Volume29.9K

Share Statistics

Shares Outstanding

Employees—

ExchangeXNAS

Listed2025-02-20

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Aspire Biopharma Holdings, Inc. Common Stock (ASBP)

What is Aspire Biopharma Holdings, Inc. Common Stock's Market Cap?: Aspire Biopharma Holdings, Inc. Common Stock's Market Cap is $12.4M, based on as-reported figures from SEC (XBRL) filings.
What is Aspire Biopharma Holdings, Inc. Common Stock's Enterprise Value?: Aspire Biopharma Holdings, Inc. Common Stock's Enterprise Value is $245.5K, based on as-reported figures from SEC (XBRL) filings.
What is Aspire Biopharma Holdings, Inc. Common Stock's Price / Sales?: Aspire Biopharma Holdings, Inc. Common Stock's Price / Sales is 127.1×, based on as-reported figures from SEC (XBRL) filings.
What is Aspire Biopharma Holdings, Inc. Common Stock's EV / Revenue?: Aspire Biopharma Holdings, Inc. Common Stock's EV / Revenue is 2.5×, based on as-reported figures from SEC (XBRL) filings.
What is Aspire Biopharma Holdings, Inc. Common Stock's Revenue (TTM)?: Aspire Biopharma Holdings, Inc. Common Stock's Revenue (TTM) is $97.7K, based on as-reported figures from SEC (XBRL) filings.
What is Aspire Biopharma Holdings, Inc. Common Stock's Net Income (TTM)?: Aspire Biopharma Holdings, Inc. Common Stock's Net Income (TTM) is -$11.0M, based on as-reported figures from SEC (XBRL) filings.
What is Aspire Biopharma Holdings, Inc. Common Stock's Diluted EPS (TTM)?: Aspire Biopharma Holdings, Inc. Common Stock's Diluted EPS (TTM) is -7.88, based on as-reported figures from SEC (XBRL) filings.
What is Aspire Biopharma Holdings, Inc. Common Stock's Net Debt?: Aspire Biopharma Holdings, Inc. Common Stock's Net Debt is -$12.2M, based on as-reported figures from SEC (XBRL) filings.